Table 4.
Correlation of BP antibody ELISA titers with disease severity in different populations
| Reference | Sample size | Result | ELISA kit used | |
|---|---|---|---|---|
|
| ||||
| Correlation between BP180 ELISA titer and disease activity | Correlation between BP230 ELISA titer and disease activity | |||
| Daneshpazhooh M, et al.[11] | 95 | Present | Absent | Euroimmun, L€ubeck, Germany |
| Current study | 30 | Present | Absent | Euroimmun, L€ubeck, Germany |
| Lee EH, et al.[12] | 47 | Present | Absent | MBL Co. Ltd, Japan |
| Cai SC, et al.[13] | 34 | Present | - | MBL Co. Ltd, Japan |
| Tsuji-Abe Y, et al.[14] | 14 | Present | - | - |
| Feng S, et al.[15] | 20 | Present | - | MBL Co. Ltd, Japan |
| Patsatsi A, et al.[16] | 39 | Present | Absent | MBL Co. Ltd, Japan |
BP - bullous pemphigoid; ELISA - enzyme linked immunosorbent assay